The Mannheim-based pharmaceutical distributor Phoenix Pharmahandel has named Dr Michael Keppel chief restructuring officer. He will advise on the company's ongoing restructuring to Professor Harald Wiedmann, Phoenix's recently appointed trustee.
The Mannheim-based pharmaceutical distributor Phoenix Pharmahandel has named Dr Michael Keppel chief restructuring officer. He will advise on the company's ongoing restructuring to Professor Harald Wiedmann, Phoenix's recently appointed trustee.
Analysts were unsure about Phoenix's fate after the death of Adolf Merckle, the company's founder, at the beginning of this...
Emerging Company Profile: Axelyf raises $2.6m seed round for lipid nanoparticle delivery platform on heels of end to US federal support for mRNA vaccines.
The France-headquartered firm’s eye drop has demonstrated efficacy in a second pivotal trial.
The company took a prophylactic C3 inhibitor out of the immunomodulatory regimen used in its Phase II study of RP-A501, lowered the dose and adjusted its use of eculizumab.
